Tarbox Family Office, Inc. Takeda Pharmaceutical CO LTD Transaction History
Tarbox Family Office, Inc.
- $606 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
68.6MCall Options Held
1.72MPut Options Held
178K-
Capital Research Global Investors Los Angeles, CA13.2MShares$189 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.6MShares$80.4 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.63MShares$66.5 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.22MShares$60.5 Million0.05% of portfolio
-
First Trust Advisors LP Wheaton, IL3.24MShares$46.5 Million0.04% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...